Article ID Journal Published Year Pages File Type
5697019 Brachytherapy 2017 6 Pages PDF
Abstract
A majority of respondents were unaware of Co-60 as a commercially available HDR source. This investigation was novel in directly assessing decision makers to establish WTP for shielding costs that source change to Co-60 may require. These results will be used to establish WTP threshold for future cost-benefit analysis.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , , ,